HORIZON-JU-GH-EDCTP3-2023-01-02
Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic
Plain-language summary
Funding to complete EDCTP2 clinical trials disrupted by COVID-19, focusing on infectious diseases and global health in Africa.
This call provides funding to finalize clinical trials originally supported by EDCTP2 that were negatively affected by the COVID-19 pandemic. It targets infectious diseases and public health research, especially in sub-Saharan Africa. The aim is to support global health and clinical research projects impacted by pandemic disruptions.
Likely relevant for
- Clinical researchers in infectious diseases
- Public health researchers
- Global health organizations
- Institutions involved in EDCTP2 projects
- Researchers focusing on Africa and sub-Saharan Africa
- Social sciences and humanities researchers in health
Project signals
Clinical trials impacted by COVID-19Focus on infectious diseases in AfricaGlobal health and public health researchUse of social sciences and humanities in health contexts
What it funds
- Finalization of clinical trials funded under EDCTP2
- Research addressing infectious diseases and public health
- Projects with a focus on Africa, especially sub-Saharan Africa
- Activities to mitigate COVID-19 pandemic impact on clinical research
Expected outcomes
- Successful completion of disrupted clinical trials
- Improved understanding and control of infectious diseases
- Strengthened global health research capacity in Africa
- Enhanced societal engagement in health research
Who can apply / participate
- Research institutions
- Universities
- Public health organizations
- Non-profit research entities
- Consortia involving African partners
- Check if single applicants or consortia are allowed
- Verify requirements for African partner involvement
- Focus on Africa, especially sub-Saharan Africa
- Likely requirement for involvement of African institutions
- Projects must be continuation of EDCTP2-funded clinical trials
- Applicants should demonstrate impact of COVID-19 on their trials
- Exact consortium size limits
- Specific eligibility of private sector entities
Must check before shortlisting
- Specific eligibility criteria regarding prior EDCTP2 funding
- Budget and funding rate details
- Consortium composition and geographic restrictions
Money
Budget details and funding rates are not stated and must be checked in the official call documents.
Application notes
- Single-stage submission model.
- Applicants must confirm eligibility based on prior EDCTP2 funding and COVID-19 impact
- Check official call for detailed application instructions and required documents
Derived from official EU Funding portal source · updated 2 Jul 2026, 10:47 UTC. Use this as a shortlisting aid; the official call text remains authoritative.
Official source text
Fine print from the EU source record. Expand when you need the original wording.